United States

Profile: Eli Lilly and Co (LLY.F)

LLY.F on Frankfurt Stock Exchange

6:29am EDT
Change (% chg)

€2.13 (+3.09%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, such as Humalog and Humalog Mix 75/25; neuroscience products, such as Cymbalta and Zyprexa; oncology products, such as Alimta and Cyramza, and cardiovascular products, such as Cialis and ReoPro. The Company's animal health products segment includes products for food animals, such as Rumensin and Posilac; products for companion animals, such as Onsior and Osurnia, and Novartis Animal Health (Novartis AH) products.

Company Address

Eli Lilly and Co

Lilly Corporate Ctr, Drop Code 1
P: +1317.2762000
F: +1317.2763492

Company Web Links